• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨膜螺旋之间的多种相互作用产生了寡聚α1b -肾上腺素能受体。

Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor.

作者信息

Carrillo Juan J, López-Giménez Juan F, Milligan Graeme

机构信息

Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom.

出版信息

Mol Pharmacol. 2004 Nov;66(5):1123-37. doi: 10.1124/mol.104.001586. Epub 2004 Aug 10.

DOI:10.1124/mol.104.001586
PMID:15304550
Abstract

Combinations of coimmunoprecipitation, single-cell fluorescence resonance energy transfer, and cell-surface time-resolved fluorescence resonance energy transfer demonstrated protein-protein interactions and quaternary structure for the alpha(1b)-adrenoceptor. Self-association of transmembrane domain 1 and its interaction with the full-length receptor indicated a symmetrical interface provided by this domain. Lack of effect of mutation of the glycophorin-A dimerization-like region within this helix demonstrated that this did not provide the molecular mechanism. Multiple interactions were observed between the alpha(1b)-adrenoceptor and fragments derived from its sequence. Fragments comprising transmembrane domains 3 and 4 and transmembrane domains 5 and 6, but not transmembrane domain 7, were also able to interact with the full-length receptor. Transmembrane domain 7 failed to interact significantly with any element of the receptor and was not transported to the cell surface after coexpression with the full-length receptor. Symmetrical interactions were also noted between fragments incorporating transmembrane domain 4, but this segment of the receptor failed to interact with transmembrane domains 1 and 2 or transmembrane domains 5 and 6. Time-resolved fluorescence resonance energy transfer studies were also consistent with contributions of transmembrane domains 1 and/or 2 and transmembrane domains 3 and/or 4 to protein-protein interactions within the quaternary structure of the alpha(1b)-adrenoceptor, and with a contribution of transmembrane domains 5 and/or 6. These data are consistent with a complex oligomeric quaternary structure of the alpha(1b)-adrenoceptor in which major, symmetrical interactions may define intradimeric contacts with other contributions, providing interdimer contacts to generate oligomeric complexes akin to those observed for murine rhodopsin. A model derived from this was developed.

摘要

免疫共沉淀、单细胞荧光共振能量转移和细胞表面时间分辨荧光共振能量转移相结合的方法,证实了α(1b)-肾上腺素能受体的蛋白质-蛋白质相互作用和四级结构。跨膜结构域1的自缔合及其与全长受体的相互作用表明,该结构域提供了一个对称界面。该螺旋内糖蛋白A二聚化样区域的突变缺乏效应,表明这不是分子机制。观察到α(1b)-肾上腺素能受体与其序列衍生片段之间存在多种相互作用。包含跨膜结构域3和4以及跨膜结构域5和6的片段,但不包括跨膜结构域7,也能够与全长受体相互作用。跨膜结构域7未能与受体的任何元件发生显著相互作用,并且在与全长受体共表达后未转运到细胞表面。在包含跨膜结构域4的片段之间也观察到对称相互作用,但该受体片段未能与跨膜结构域1和2或跨膜结构域5和6相互作用。时间分辨荧光共振能量转移研究也与跨膜结构域1和/或2以及跨膜结构域3和/或4对α(1b)-肾上腺素能受体四级结构内蛋白质-蛋白质相互作用的贡献一致,也与跨膜结构域5和/或6的贡献一致。这些数据与α(1b)-肾上腺素能受体的复杂寡聚四级结构一致,其中主要的对称相互作用可能定义二聚体内的接触,其他贡献提供二聚体间的接触,以产生类似于小鼠视紫红质的寡聚复合物。由此得出了一个模型。

相似文献

1
Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor.跨膜螺旋之间的多种相互作用产生了寡聚α1b -肾上腺素能受体。
Mol Pharmacol. 2004 Nov;66(5):1123-37. doi: 10.1124/mol.104.001586. Epub 2004 Aug 10.
2
Oligomeric structure of the alpha1b-adrenoceptor: comparisons with rhodopsin.α1b - 肾上腺素能受体的寡聚体结构:与视紫红质的比较。
Vision Res. 2006 Dec;46(27):4434-41. doi: 10.1016/j.visres.2006.08.007. Epub 2006 Sep 26.
3
The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function.α1b -肾上腺素能受体以高阶寡聚体形式存在:受体成熟、表面转运及功能需要有效的寡聚化。
Mol Pharmacol. 2007 Apr;71(4):1015-29. doi: 10.1124/mol.106.033035. Epub 2007 Jan 12.
4
The specificity and molecular basis of alpha1-adrenoceptor and CXCR chemokine receptor dimerization.α1肾上腺素能受体与CXCR趋化因子受体二聚化的特异性及分子基础。
J Mol Neurosci. 2005;26(2-3):161-8. doi: 10.1385/JMN:26:2-3:161.
5
High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor.人α1A -肾上腺素能受体C末端剪接变体之间的高亲和力相互作用产生同二聚体和异二聚体,但不会生成α1L -肾上腺素能受体。
Mol Pharmacol. 2004 Aug;66(2):228-39. doi: 10.1124/mol.66.2.228.
6
Conopeptide ρ-TIA defines a new allosteric site on the extracellular surface of the α1B-adrenoceptor.蜂毒素 ρ-TIA 在 α1B-肾上腺素能受体细胞外表面定义了一个新的变构位点。
J Biol Chem. 2013 Jan 18;288(3):1814-27. doi: 10.1074/jbc.M112.430785. Epub 2012 Nov 26.
7
NMR-based approach to measure the free energy of transmembrane helix-helix interactions.基于核磁共振的方法来测量跨膜螺旋-螺旋相互作用的自由能。
Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):164-72. doi: 10.1016/j.bbamem.2013.08.021. Epub 2013 Sep 10.
8
Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers.药理学伴侣对寡聚化缺陷型α(1b)-肾上腺素能受体突变体的细胞表面递送和结构重组证明了GPCR寡聚体的膜靶向作用。
Biochem J. 2009 Jan 1;417(1):161-72. doi: 10.1042/BJ20081227.
9
Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization.α1a-和α1b-肾上腺素能受体亚型的寡聚化。对受体内化的潜在影响。
J Biol Chem. 2003 Oct 10;278(41):40239-51. doi: 10.1074/jbc.M306085200. Epub 2003 Jul 29.
10
Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.神经/表皮生长因子受体2(neu/erbB-2)受体二聚化及转化激活的跨膜结构域二聚体界面:分子动力学模拟揭示的模型
J Biomol Struct Dyn. 2001 Aug;19(1):15-31. doi: 10.1080/07391102.2001.10506717.

引用本文的文献

1
The World of GPCR dimers - Mapping dopamine receptor D homodimers in different activation states and configuration arrangements.GPCR二聚体的世界——绘制处于不同激活状态和构象排列的多巴胺受体D同型二聚体图谱。
Comput Struct Biotechnol J. 2023 Sep 3;21:4336-4353. doi: 10.1016/j.csbj.2023.08.032. eCollection 2023.
2
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.血管紧张素和内皮素受体结构及其对信号调节和药物靶向的影响。
Front Endocrinol (Lausanne). 2022 Apr 19;13:880002. doi: 10.3389/fendo.2022.880002. eCollection 2022.
3
Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities.
阿片类和肾上腺素能配体与受体的共同进化:共享、互补模块解释功能相互作用的进化并提示新的工程可能性。
Life (Basel). 2021 Nov 10;11(11):1217. doi: 10.3390/life11111217.
4
G protein-coupled receptor heterocomplexes in neuropsychiatric disorders.G 蛋白偶联受体异源复合物与神经精神疾病。
Prog Mol Biol Transl Sci. 2013;117:187-205. doi: 10.1016/B978-0-12-386931-9.00008-8.
5
Novel insights on thyroid-stimulating hormone receptor signal transduction.促甲状腺激素受体信号转导的新见解。
Endocr Rev. 2013 Oct;34(5):691-724. doi: 10.1210/er.2012-1072. Epub 2013 May 3.
6
Receptor oligomerization: from early evidence to current understanding in class B GPCRs.受体寡聚化:从 B 类 G 蛋白偶联受体的早期证据到当前认识。
Front Endocrinol (Lausanne). 2013 Jan 4;3:175. doi: 10.3389/fendo.2012.00175. eCollection 2012.
7
BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues.BRET 和时间分辨荧光共振能量转移技术研究 GPCR 寡聚化:从细胞系到天然组织。
Front Endocrinol (Lausanne). 2012 Jul 23;3:92. doi: 10.3389/fendo.2012.00092. eCollection 2012.
8
Protein-protein interactions at the adrenergic receptors.肾上腺素能受体的蛋白-蛋白相互作用。
Curr Drug Targets. 2012 Jan;13(1):15-27. doi: 10.2174/138945012798868489.
9
Structural basis of M3 muscarinic receptor dimer/oligomer formation.M3 毒蕈碱型乙酰胆碱受体二聚体/寡聚体形成的结构基础。
J Biol Chem. 2011 Aug 12;286(32):28584-98. doi: 10.1074/jbc.M111.259788. Epub 2011 Jun 17.
10
GPCR oligomers in pharmacology and signaling.G 蛋白偶联受体寡聚体在药理学和信号转导中的作用。
Mol Brain. 2011 May 27;4(1):20. doi: 10.1186/1756-6606-4-20.